Acrux, Ltd.

Sponsors are encouraged about prospects for FDA approval of the first drugs for female sexual desire disorders following a pair of meetings with patients and clinician experts, despite a backlash agai

MELBOURNE – In a new feature, PharmAsia News combs through earnings reports to bring you highlights on Australian biotech firms. We start with CSL Ltd. , Acrux Ltd. , Pharmaxis Ltd. and M

Public unlisted Australian drug development company Hunter Immunology is recommending that its shareholders accept the takeover offer from listed biotech firm Probiomics. The company's four largest sh

An Australian private member's bill which proposes a ban on the patenting of human genes and biological materials will have ramifications not just for the local R&D industries. It could change the way